ENTITY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (1349 HK)

122
Analysis
Health CareChina
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is primarily engaged in the innovative research and development, production, and marketing of biopharmaceuticals. The company offers a range of products including photodynamic technology drugs like aminolevulinic acid hydrochloride and hemoporfin, doxorubicin liposome under the Libord brand, genetic engineering drugs, and oral solid preparation technology drugs. It is headquartered in Zhangjiang Hi-Tech Park, Pudong, Shanghai, China, and was established in November 1996.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x